Senior Politicians Urge Government to Fund Life-Saving Drug for Rare Disorder
Senior members of the Fianna Fáil party are calling on the Irish Government to intervene in a decision made by the Health Service Executive (HSE) regarding a new medication. The drug, called Skyclarys, is used to treat Friedreich’s ataxia, a rare genetic condition that causes progressive damage to the nervous system.
Friedreich’s ataxia affects a person’s movement and can lead to serious health complications over time. Patients and their families have been waiting for the HSE to approve the funding of this treatment so that it can be made available to those who need it most in Ireland.
However, the HSE has currently decided against providing the drug through the public health system. This has led to frustration among patient advocates and politicians who argue that the medication is essential for improving the quality of life for those living with this condition.
Politicians are now asking the Government to overrule the HSE’s decision. They believe that the state has a responsibility to ensure that patients with rare diseases have access to life-saving treatments, even when the costs are high.
The debate highlights the ongoing challenges of funding expensive medicines for rare conditions within the Irish health system. As discussions continue, families affected by the disorder are waiting to see if the Government will take action to make the drug available.